World's leading clinical conference on bone, joint and muscle health
Programme
Sunday April 14th - GMT Time zone
08:00 - 09:00
Non-Sponsored Symposia
08:00
MR2
Sarcopenia in metabolic and neurological diseases
Chairpersons :
Panagiotis Athanassiou
& Yannis Dionyssiotis
- Introduction in Sarcopenia
- Sarcopenia in Metabolic Diseases
- Sarcopenia in Diabetes Mellitus
- Sarcopenia in Neurological Disorders
08:00
MR3
Neurocardiovascular disease and osteoporosis: recently met or a long relationship?
Chairperson :
Geraldine Altamar Canales
- Osteoporosis and cardiovascular risk: old friends?
- Osteoporosis and dementia: where are we going?
- Treatments for osteoporosis and cardiovascular events: what do we know?
08:00
MR4
Managing pregnancy-and lactation-associated osteoporosis
Chairpersons :
Maria Luisa Brandi
& Nicholas Harvey
- Bone fragility and osteoporosis in young adults
- Assessment of bone health in pregnancy
- Management of bone fragility in pregnant women
08:00
MR6
Bone health solutions: maybe it’s time for a change?
Chairperson :
P. Dean Cummings
- The Critical Shift to a Proactive Approach to Bone Health
- Optimal Clinical Paradigm: 4-Pillar Evaluation, Integrated Profile, and Multidisciplinary Care Plan
- Bone Health Solutions
08:00
MR7
Navigating heterogeneity in vitamin D supplementation: implications for regional health - a Latin American perspective
Chairperson :
José Francisco Torres Naranjo
- Vitamin D Status and Diverse Medical Practices in Mexico and Latin America
- Global and Regional Dynamics: Heterogeneity in Vitamin D Supplementation Across Latin America
- Formulating Unity: Mexico's Approach to the National Joint Position
08:00
MR8
Fractures-E3 study: fractures in Sub-Saharan Africa – epidemiology, ethnography and economic impact
Chairpersons :
Tereza Hough
& Tafadzwa Madanhire
- The impact of menopause and HIV on midlife bone health
- The challenges of poor musculoskeletal health in The Gambia
- Hip fracture incidence and outcomes in Zimbabwe
- The economic impact of hip fracture in Zimbabwe and South Africa
08:00 - 09:00
MR5
SICOT-ESCEO-IOF Symposium
Surgical Treatment of Fragility Fractures
Chairperson :
Ilir Hasani
- Osteoporotic Spine Fractures
- Trends in the management of osteoporotic pelvic fractures
- Will a treatment Protocol including OF classification provide clear guidelines for osteoporotic thoracolumbar fracture management? Can we avoid overtreatment or undertreatment?
- Osteoporotic Hip Fracture
- Discussion
09:00 - 10:00
Meet-The-Expert Session
09:00
MR3
Denosumab cessation: a practical approach in long-term treatment
09:00
MR4
Quality of life assessment in sarcopenia - Lessons for cohort and clinic
09:00
MR5
Phosphate wasting for the osteoporosis doctor
09:00
MR6
Management of GIOP in Latin America
09:00 - 10:00
Poster Area
Poster Viewing Session III
10:00 - 12:00
Auditorium A
Scientific Session VII
Chairpersons :
Salvatore Minisola
& Etienne Cavalier
10:00
Auditorium A
Plenary Lecture 9
New perspectives in osteoarthritis management
10:30
Auditorium A
Presentation of the ESCEO-IOF Young Investigator Awards
10:40
Auditorium A
Oral communications selected from abstracts
10:40
Auditorium A
Oral communication selected from abstracts
OC35: FRACTURE RATE AND LOCATION IN ADULTS WITH HYPOPHOSPHATASIA WITH ONE VERSUS MULTIPLE ALPL VARIANTS: DATA FROM THE GLOBAL HPP REGISTRY
Presenting author:
Authors:
10:50
Auditorium A
Oral communication selected from abstracts
OC36: IS THERE AN ASSOCIATION BETWEEN BIRTH WEIGHT OR GESTATIONAL AGE AND FRACTURE RISK IN YOUNG ADULTS?
Presenting author:
Authors:
11:00
Auditorium A
Oral communication selected from abstracts
OC37: AIR POLLUTION AND BONE HEALTH OUTCOMES: PERIODS OF SUSCEPTIBILITY FROM PREGNANCY TO CHILDHOOD
Presenting author:
Authors:
11:10
Auditorium A
Oral communication selected from abstracts
OC38: FAMILY HISTORY OF FRACTURE AND FRACTURE RISK: A META-ANALYSIS TO UPDATE THE FRAX® RISK ASSESSMENT TOOL
Presenting author:
Authors:
11:20
Auditorium A
Oral communication selected from abstracts
OC39: SEX DEPENDENT ASSOCIATIONS BETWEEN BMI AND FRACTURE RISK: AN INTERNATIONAL META-ANALYSIS
Presenting author:
Authors:
11:30
Auditorium A
Plenary Lecture 10
Precision medicine approaches in the assessment of fracture risk
12:00 - 13:00
Non-Sponsored Symposia
12:00
MR1
Patient and public involvement and engagement (PPI/E) in musculoskeletal research: an idea whose time has firmly come (and we are sharing the resources to help you get started)
Chairperson :
Angie Botto-van Bemden
- WHY; Introduction to PPI, overview of impact and progress
- WHAT; PPI Article Collection as a global resource
- HOW; Implementing patient partnerships
- WHERE we are going; PPI opportunities
12:00
MR2
Hyperthyroidism and osteoporosis
Chairperson :
Ifigenia Kostoglou-Athanassiou
- Hyperthyroidism. Etiology and clinical manifestations
- Hyperthyroidism. Psychosocial implications
- Hyperthyroidism and sarcopenia
- Hyperthyroidism and osteoporosis. Pathophysiology and management
12:00
MR3
Bone health and the spine: opportunities to drive public and health care professional education and action
Chairperson :
Rita Roy
- Osteoporosis and the Spine: Key Statistics and an Overview of the National Spine Health Foundation’s Key Patient and Health Care Professional Initiatives
- A Spine Surgeon Perspective on the Need for Perioperative Spine and Bone Health Optimization
- Spine and Bone Health Patient Educational Gaps and Needs
- A European Perspective on Key Spine Surgeon Gaps in the Diagnosis and Treatment of Osteoporotic Patients
12:00
MR4
Glucocorticoids in the treatment of rheumatoid arthritis. Friend or foe?
Chairpersons :
Osvaldo Daniel Messina
& Giovanni Adami
- GCS in the treatment of rheumatoid arthritis. Friends
- Glucocorticoids “foe”
12:00
MR5
Clinical conundrums – bone health management in special scenarios
Chairperson :
Muhammad Nisar
- Managing eGFR and bone
- Managing Aromatase inhibitor induced bone loss
12:00
MR6
Osteoporosis and cardiovascular disease: new insight
Chairperson :
Sekib Sokolovic
- Osteocalcin: Old-New Marker- Can it be prognostic for CVD?
- The Hidden upstairs between Bone density and Cardiovascular Mortality
- Osteoporosis and Cardiovascular Diseases: A case-series study
12:00
MR7
Fracture prevention strategies and antiosteoporotic medications in elderly population
Chairpersons :
Pınar Borman
& Belgin Karaoglan
- Prevention of Hip Fractures
- Antiosteoporotic Agents and Fracture Healing
- Rehabilitation of Hip Fractures
12:00
MR8
Osteoporosis: impact on health & economics
Chairpersons :
Yasser El Miedany
& Mathias Toth
- Health Economics of Osteoporosis: The missed interventional threshold
- Direct cost of osteoporotic Hip fractures
- Economic Evaluation of FLS in Egypt